Beta
Talinolol
medication Under reviewA cardioselective beta-1 adrenergic receptor blocker used in the management of hypertension and angina pectoris.
Research summary
Scientific evidence on talinolol centers on its pharmacokinetics in healthy humans, demonstrating substantial variability in absorption, clearance, and exposure due to intestinal P-gp activity. Studies consistently show that P-gp inhibitors like erythromycin increase its bioavailability by reducing efflux, while inducers decrease it, with low heritability suggesting environmental factors dominate variability. No consensus exists on therapeutic benefits for healthy subjects, as research focuses on its role as a probe drug rather than a supplement with direct health applications.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!